Gilead Sciences (GILD)

Company Ticker Sector | Industry Quality PAR
Gilead Sciences GILD Healthcare | Biotechnology 65 8.3%
Current Price (03/26) $64.24
CAPS Rating (Rate this stock on CAPS) Foolcaps 5
Expected Income Statement
Current Sales 20,728.8
Sales Growth Forecast 2.0%
Net Profit Margin 36.0%
Projected Shares Outstanding 1,279.70
EPS - Five year Forecast $6.44
Average P/E Ratio 13.0
Projected Average Price $83.73
Price Appreciation (Annualized) 5.4%
Annual Dividend Yield 2.9%
Projected Annual Return 8.3%
Quality
Financial Strength 95 23.7
EPS Stability 50 12.4
Industry Sales Growth Rate 16.5% 1.5
Industry Net Profit Margin 29.0% 15.5
Calculated Quality Rating 53.1
Fool CAPS

Total Players

3513 Outperforms
90 Underperforms
 

All-Stars (725)

711 Outperforms (98%)
14 Underperforms
 
Fundamental Data Updated: 01/04/2019

MIPAR 8.9%  
Sweet Spot 13.9% - 18.9%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 92 15.9%
BIIB 81 17.8%
REGN 82 17.0%
CBPO 73 13.9%
AMGN 91 8.5%

Top In Healthcare

Ticker Quality PAR
ABBV 97 16.2%
ALGN 99 15.3%
CMD 92 16.2%
JAZZ 92 15.9%
CNC 80 19.0%